Andrographolide: A New Plant-Derived Antineoplastic Entity on Horizon
2011

Andrographolide: A New Plant-Derived Antineoplastic Entity

publication Evidence: moderate

Author Information

Author(s): Astha Varma, Harish Padh, Neeta Shrivastava

Primary Institution: B. V. Patel Pharmaceutical Education & Research Development Centre, India

Hypothesis

Can andrographolide from Andrographis paniculata serve as an effective anticancer agent?

Conclusion

Andrographolide shows significant anticancer and immunomodulatory activities, warranting further research.

Supporting Evidence

  • Andrographolide induces cell-cycle arrest and apoptosis in various cancer cell lines.
  • It enhances the immune response against cancer cells.
  • The compound shows potential in combination therapies with other anticancer agents.
  • Andrographolide has anti-inflammatory and anti-angiogenic properties.
  • It has been used in traditional medicine for treating various ailments.

Takeaway

Andrographolide is a natural compound from a plant that may help fight cancer by stopping cancer cells from growing and helping the immune system.

Methodology

The article reviews various studies on the anticancer properties of andrographolide, including its effects on cell-cycle arrest and apoptosis in cancer cells.

Limitations

Most data is based on in vitro studies, with a lack of concrete evidence from mouse models or clinical trials.

Digital Object Identifier (DOI)

10.1093/ecam/nep135

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication